Cosmo Pharm, Romanian dietary supplement producer, reported a 42 percent increase in sales in 2025 compared to 2024. This result was supported by wider retail coverage, export growth, strong momentum in specific supplement categories, and the continued development of online channels.

At the same time, exports continued to gain traction, increasing by 25 percent as the company expanded its international presence through partnerships and new markets. The focus has been on the Middle East – particularly the United Arab Emirate – as well as other strategic regions, in line with the internationalization strategy.

The manufacturer currently offers a portfolio of over 200 dietary supplements, including 70 registered trademarks, spanning areas such as longevity, neurocerebral health, immunity, detoxification, hormonal balance, and women’s health.

“2025 was a year of accelerated progress for COSMO PHARM, in which investments in our portfolio, international expansion, and the strengthening of sales channels delivered solid results. Sales growth confirms that people are increasingly interested in effective, safe health solutions tailored to modern lifestyles, and we remain focused on meeting these expectations through innovation and quality,” said Alina Birău, Commercial Director, Cosmo Pharm.

In 2026, COSMO PHARM aims to maintain this pace by investing in AI and digitalization, with plans to implement applications and solutions designed to improve the consumer experience and strengthen engagement with younger audiences.

In addition, the company is considering expanding its storage capacity to keep up with increasing demand and higher volumes of finished products, supported by portfolio diversification and entry into new markets.